The levonorgestrel intrauterine system as an alternative to hysterectomy for the treatment of idiopathic menorrhagia

Gynecological Endocrinology

Volumn 25, Issue 9, 2009, Pages 581-586

  Goñi, Álvaro Zapico ^a   Lacruz, Ramón Lanzón ^b   Paricio, Juan José Parilla ^c   Hernández Rivas, Francisco J ^d  

^a HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

^b HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^d Bayer Schering Pharma   (Spain)

Author keywords

Hysterectomy; Intrauterine system; Levonorgestrel; Menorrhagia; Menstrual bleeding

Indexed keywords

CONTRACEPTIVE AGENT; GESTAGEN; LEVONORGESTREL; TRANEXAMIC ACID;

ABDOMINAL PAIN; ACNE; ADULT; APATHY; ARTICLE; ASTHENIA; BLEEDING; BREAST TENSION; DISEASE COURSE; DIZZINESS; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HEADACHE; HUMAN; HUMOR; HYPERTENSION; HYSTERECTOMY; MAJOR CLINICAL STUDY; MENORRHAGIA; MENSTRUAL CYCLE; METRORRHAGIA; MIGRAINE; NAUSEA; OBSERVATIONAL STUDY; PAIN; PATIENT SATISFACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; SANITARY PAD; SIDE EFFECT; SPAIN; TACHYCARDIA; TREATMENT DURATION; TREATMENT INDICATION; VOMITING; VULVITIS; WEIGHT GAIN;

ADULT; FEMALE; HUMANS; HYSTERECTOMY; INTRAUTERINE DEVICES, MEDICATED; LEVONORGESTREL; MENORRHAGIA; MENSTRUAL CYCLE; MIDDLE AGED; PATIENT SATISFACTION; PATIENT SELECTION; PROSPECTIVE STUDIES; QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 70350686810     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.1080/09513590902972034     Document Type: Article

References (36)

1. Vessey MP, Villard-Mackintosh L, McPherson K, Coulter A, Yeates D. The epidemiology of hysterectomy: findings in a large cohort study. Br J Obstet Gynaecol 1992;99:402-427.
2. Settnes A, Jorgensen T, Lange AP. Hysterectomy in Danish women: weight related factors, psychological factors, and lifestyle variables. Obstet Gynecol 1996;88:99-105.
3. Settnes A, Jorgensen T. Hysterectomy in a Danish cohort. Prevalence, incidence and socio-demographic characteristics. Act Gynecol Scand 1996;75:274-280.
4. Wilcox L, Koonin L, Pokras R, Strauss LT, Xin Z, Peterson H. Hysterectomy in the United States, 1988-1990. Obstet Gynecol 1994;83:549-555.
5. Carlson KJ, Miller BA, Fowler FJ. The Maine women health study. I. Outcomes of hysterectomy. Obstet Gynecol 1994;83: 556-565.
6. Nilsson CG, Haukamaa M, Vierola H, Luukkainen T. Levonorgestrel plasma concentrations and hormone profiles after insertion and after one year of treatment with a levonorgestrel-IUD. Contraception 1980;21:225-238.
7. Nilsson CG, Lähteenmäki PLA, Robertson DN. Plasma concentrations of levonorgestrel as a function of the release rate of levonorgestrel from medicated intrauterine devices. Acta Endocrinol 1980;93:380-384.
8. Nilsson CG, Haukamaa M, Vierola H, et al. Tissue concentrations of levonorgestrel in women using a levonorgestrel- releasing IUD. Clin Endocrinol 1982;17:529-536.
9. Silverberg SG, Haukkamaa M, Arko H, Nillson CG, Luukkainen T. Endometrial morphology during long term use of levonorgestrel releasing intrauterine device. Int J Gynecol Pathol 1986;5:235-241.
10. Pakarinen P, Luukkainen T, Laine H, Lahteenmake P. The effect of local intrauterine levonorgestrel administration on endometrial thickness and uterine blood circulation. Hum Reprod 1995;10:2390-2394.
11. Andersson K, Odlind V, Rybo G. Levonorgestrel-releasing and copperreleasing (Nova T) IUDs during five years of use: a randomized comparative trial. Contraception 1994;49:56-72.
12. Luukkainen T, Toivonen J. Levonorgestrel-releasin IUD as a method of contraception with therapeutic properties. Contraception 1995;52:269-276.
13. Luukkainen T, Lähteenmäki P, Toivonen J. Levonorgestrel releasing intrauterine device. Ann Med 1990;22:85-90.
14. Crosignani PG, Vercellini P, Mosconi P,Oldani S, Cortesi I, Di Giorgio O. Levonorgestrel-releasing intrauterine device versus hysteroscopic endometrial resection in the treatment of dysfunctional uterine bleeding. Obstet Gynecol 1997;90:257-263.
15. Milsom I, Andersson K, Andersch B, Ribo G. A comparison of flurbiprofen, tranexamic acid, and a levonorgestrel releasing intrauterine contraceptive device in the treatment of idiopathic menorrhagia. Am J Obstet Gynecol 1991;164:879-883.
16. Lähteenmäki P, Haukkamaa M, Puolakka J, Riikonen V, Sainios S, Suvisani J, Nilsson C. Open randomised study of use of levonorgestrel releasing intrauterine system as alternative to hysterectomy. BMJ 1998;316:1122-1126.
17. Andersson K, Rybo G. levonorgestrel-releasing intrauterine device in the treatment of menorrhagia. Br J Obstet Gynecol 1995;102:249-254.
18. Fattore G, Lazzaro C. Analisi dei costi del trattamento della menorragia: un confronto tra isterectomia, ablazione endometriale e un sistema intrauterino di rilascio di levonorgestrel (Mirena). PharmacoEconomics 1999;1:1-15.
19. Hurskainen R, Teperi J, Rissanen P, Aalto AM, Grenan S, Kivelä A, Kujansuu E, Vuorma S. Quality of life and cost - effectiveness of levonorgestrel - releasing intrauterine system versus hysterectomy for treatment of menorrhagia: a randomised trial. Lancet 2001;357:273-277.
20. Hurskainen R, Teperi J, Rissanen P, Aalto AM, Grenman S, Kivelä A, Kujansuu E, Vuorma S, Yliskoski M, Paavonen J. Clinical outcomes and cost with the levonorgestrel-releasing intrauterine system or hysterectomy for the treatment of menorrhagia. Randomized trial 5-year follow-up. JAMA 2004;291:1456-1463. (Pubitemid 38543736)
21. Carlson KJ, Miller BA, Fowler FJ. The Maine women health study. II. Outcomes of non surgical management of leiomyomas, abnormal bleeding, and chronic pelvic pain. Obstet Gynecol 1994;83:566-572.
22. Chuong CJ, Brenner PF. Management of abnormal uterine bleeding. Am J Obstet Gynaecol 1996;175:787-792.
23. Carlson KJ, Schiff I. Alternatives to hysterectomy for menorrhagia. Editorial. N Engl J Med 1996;35:198-199.
24. Hallberg L, Högdahl AM, Nilsson L, Rybo G. Menstrual blood loss-a population study: variation at different ages and attempts to define normality. Acta Obstet Gynecol Scand 1966;45:320-351.
25. Vilagut G, Ferrer M, Rajmil L, Rebollo P, Permanyer-Miralda G, Quintana JM, Santed R, Valderas JM, Ribera A, Domingo- Salvany A, et al. The Spanish version of the hort Form 36 Health Survey: a decade of experience and new developments. Gac Sanit 2005;19:135-150.
26. Clegg JP, Guest JF, Hurskainen R. Cost-utility of levonorgestrel intrauterine system compared with hysterectomy and second generation endometrial ablative technique in managing patients with menorrhagia in the UK. Curr Med Res Opin 2007;23:1637-1648.
27. Bush T. Beyond HERS: some (not so) random thoughts on randomized clinical trials. Int J Fertil Womens Med 2001; 46:55-59.
28. Nagrani R, Bowen-Simpkins P, Barrington JW. Can the levonorgestrel- releasing intrauterine system replace surgical treatment for the management of menorrhagia? BJOG 2002;109:345-347.
29. Edelman A, Lew R, Cwiak C, Nichols M, Jensen J. Acceptability of contraceptive-induced amenorrhea in a racially diverse group of US women. Contraception 2007; 75:450-453.
30. Glasier AF, Smith KB, van der Spuy ZM, Ho PC, Cheng L, Dada K, Wellings K, Baird DT. Amenorrhea associated with contraception - an international study on acceptability. Contraception 2003;67:1-8.
31. Xiao B, Wu S-C, Chong J, Zeng T, Han LH, Luukkainen T. Therapeutic effects of the levonorgestrel-releasing intrauterine system in the treatment of idiopathic menorrhagia. Fert Ster 2003;79:963-969.
32. Busfield RA, Farguhar CM, Sowter MC, Lethaby A, Sprecher M, Yu Y, Sadler LC, Brown P, Johnson N. A randomised trial comparing the levonosgestrel intrauterine system and the thermal balloon ablation for heavy menstrual bleeding. BJO 2006;113:257-263.
33. Radesic B, Aharma A. Levonorgestrel-releasing intrauterine system for treating menstrual disorders: a patient satisfaction questionnaire. Aust N Z J Obstet Gynaecol 2004;44:247-251.
34. Istre O, Trolle B. Treatment of menorrhagia with the levonorgestrel intrauterine system versus endometrial resection. Fert Ster 2001;76:304-309.
35. Monteiro I, Bahamondes L, Diaz J, Perrotti M, Petta C. Therapeutic use of levonorgestrel-releasing intrauterine system in women with menorrhagia: a pilot study. Contraception 2002;65:325-328.
36. Lete I, Bermejo R, Coll C, Dueñas JL, Doval JL, Martínez- Salmeán J, Masset J, Parrilla JJ, Serrano I. Use of contraceptive methods in Spain, results of a national survey. Contraception 2001;63:235-238. (Pubitemid 32480207)